# LAP100 (NCT06958328)

> Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06958328
- Phase: PHASE3
- Status: RECRUITING
- Sponsor: NRG Oncology
- Conditions: Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8
- Interventions: Biopsy Procedure; Biospecimen Collection; Capecitabine; Computed Tomography; Dose-escalated Radiation Therapy; Fluorouracil; Gemcitabine; Irinotecan Hydrochloride; Irinotecan Sucrosofate; Leucovorin Calcium; Magnetic Resonance Imaging; Nab-paclitaxel; Observation Activity; Oxaliplatin; Positron Emission Tomography; Questionnaire Administration; Radiation Therapy; Tumor Treating Fields Therapy
- Enrollment: 356
- Primary outcome: Overall survival (OS)

## Commentary we found

- X threads: 56
- X videos: 8
- YouTube: 4
- Podcasts: 1

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=lap100-nct06958328

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06958328", "email": "<work email>"}; the inbox owner confirms by the emailed link.